Provided by Tiger Trade Technology Pte. Ltd.

China Concept Stocks

266.535
-16.104-5.70%
Number of Gainers:1
Number of Losers:9
Number of Flat:32
PE:- -
High:277.268
Open:276.011
Low:265.581
Close:282.638
Volume:34.45M
Turnover:48.33M
Market Cap:15.28B
Float Cap:7.44B

Loading ...

Bubs Australia Shares Set for 15% Weekly Gain on FDA Approval for Infant Formula Products

Reuters
·
Sep 11

Australia's Mining and Energy Union: Yancoal Told Workers at Premier Coal They Cannot Have Both Decent Pay Rises and Protection for Redundancy Entitlements

THOMSON REUTERS
·
Sep 10

Bubs Australia Ltd-FDA Approval Webinar Presentation

THOMSON REUTERS
·
Sep 10

Australia's Mining & Energy Union-Workers at Yancoal’s Premier Coal Mine Overwhelmingly Voted in Favour of Protected Industrial Action

THOMSON REUTERS
·
Sep 09

Australia's Meu - over 90% of Meu Members Supported Every Form of Action Proposed Including Stoppages of over 12 Hours

THOMSON REUTERS
·
Sep 09

Australia's Meu - Australian Manufacturing Workers’ Union Members Also Overwhelmingly Backed Action, with About 93% Voting in Support

THOMSON REUTERS
·
Sep 09

Healius Says Citigroup Becomes Substantial Holder, Shares Up 3%

MT Newswires Live
·
Sep 08

Bubs Australia Ltd-FDA Approval Webinar Notification

THOMSON REUTERS
·
Sep 08

Bubs Australia Extends Rally After Infant Formulas Get US FDA Approval

Reuters
·
Sep 08

Ord Minnett Downgrades Paladin Energy to Sell from Lighten; Price Target is AU$9

MT Newswires Live
·
Sep 07

N1 - Remains Focused on "Disciplined" Underwriting, Others

THOMSON REUTERS
·
Sep 07

N1 Holdings Ltd - Continues to Maintain Its Long-Established Approach to Property-Backed Private Lending

THOMSON REUTERS
·
Sep 07

Mindax Executes Binding Convertible Note Deed with L&Y to Raise A$3.25 Million

Reuters
·
Sep 07

Bubs Australia Jumps 45% on FDA Approval for Infant Formula Products

Reuters
·
Sep 07

Bubs Australia Ltd - Bubs Secures Permanent US FDA Approval for Infant Formula

THOMSON REUTERS
·
Sep 07

Bubs Australia - to Pursue US Private Label Infant Nutrition Segment

THOMSON REUTERS
·
Sep 07

Bubs Australia - Secures Permanent FDA Authorisation for Infant Formula Products

THOMSON REUTERS
·
Sep 07

Mindax - Note is Unsecured, 10% Interest, 12-Month Term, Conversion Price A$0.033 Per Share

THOMSON REUTERS
·
Sep 07

Mindax - Executes Binding Convertible Note Deed with L&Y to Raise A$3.25 Mln

THOMSON REUTERS
·
Sep 07

Bubs Australia - Requests Trading Halt Pending FDA Update Announcement

THOMSON REUTERS
·
Sep 04